Health & TechGenetic testing led a Michigan man to a drug that stopped his pancreatitis attacks
After genetic testing found a rare triglyceride disorder, a Michigan man entered a trial of Tryngolza, approved by the FDA in June 2026. Michigan Medicine reports that decades of pancreatitis attacks then stopped. That is his course, not a result for every patient.
Verified · Michigan Medicine